Literature DB >> 7574506

A functional classification scheme for beta-lactamases and its correlation with molecular structure.

K Bush1, G A Jacoby, A A Medeiros.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7574506      PMCID: PMC162717          DOI: 10.1128/AAC.39.6.1211

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  314 in total

Review 1.  Characterization of beta-lactamases.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

3.  Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.

Authors:  T Sawai; K Tsukamoto
Journal:  J Antibiot (Tokyo)       Date:  1982-11       Impact factor: 2.649

4.  Comparison of the substrate specificities of the -lactamases from Klebsiella aerogenes 1082E and Enterobacter cloacae P99.

Authors:  M J Marshall; G W Ross; K V Chanter; A M Harris
Journal:  Appl Microbiol       Date:  1972-04

5.  Partial characterization of Nocardia farcinica beta-lactamases.

Authors:  V A Steingrube; R J Wallace; B A Brown; Y Zhang; L C Steele; G Young; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

6.  Detection of PSE-2 beta-lactamase in enterobacteria.

Authors:  D M Livermore; J P Maskell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

Authors:  G C Paul; G Gerbaud; A Bure; A M Philippon; B Pangon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Authors:  T Iwahi; K Okonogi; T Yamazaki; S Shiki; M Kondo; A Miyake; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

10.  Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.

Authors:  G Vedel; A Belaaouaj; L Gilly; R Labia; A Philippon; P Névot; G Paul
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

View more
  695 in total

1.  Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

Authors:  M B Avison; C S Higgins; C J von Heldreich; P M Bennett; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands.

Authors:  M Yuan; L M Hall; J Hoogkamp-Korstanje; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-].

Authors:  B Guerra; S M Soto; J M Argüelles; M C Mendoza
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica.

Authors:  F Laurent; L Poirel; T Naas; E B Chaibi; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  Class C beta-lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates.

Authors:  A Bulychev; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

Review 7.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

8.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  C C Sanders; M Peyret; E S Moland; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

10.  Nucleotide sequence of the bla(RTG-2) (CARB-5) gene and phylogeny of a new group of carbenicillinases.

Authors:  D Choury; M F Szajnert; M L Joly-Guillou; K Azibi; M Delpech; G Paul
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.